78 related articles for article (PubMed ID: 16500023)
1. Role of bone morphogenetic proteins in transitional cell carcinoma cells.
Kim IY; Kim SJ
Cancer Lett; 2006 Sep; 241(1):118-23. PubMed ID: 16500023
[TBL] [Abstract][Full Text] [Related]
2. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.
Kim IY; Lee DH; Lee DK; Kim WJ; Kim MM; Morton RA; Lerner SP; Kim SJ
Cancer Res; 2004 Oct; 64(20):7355-60. PubMed ID: 15492256
[TBL] [Abstract][Full Text] [Related]
3. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H
Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.
Kim IY; Lee DH; Lee DK; Kim BC; Kim HT; Leach FS; Linehan WM; Morton RA; Kim SJ
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6046-51. PubMed ID: 14676131
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
[TBL] [Abstract][Full Text] [Related]
6. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells.
Jaatinen R; Bondestam J; Raivio T; Hildén K; Dunkel L; Groome N; Ritvos O
J Clin Endocrinol Metab; 2002 Mar; 87(3):1254-61. PubMed ID: 11889196
[TBL] [Abstract][Full Text] [Related]
7. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts.
Akiyama S; Katagiri T; Namiki M; Yamaji N; Yamamoto N; Miyama K; Shibuya H; Ueno N; Wozney JM; Suda T
Exp Cell Res; 1997 Sep; 235(2):362-9. PubMed ID: 9299160
[TBL] [Abstract][Full Text] [Related]
8. Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL).
Dzietczenia J; Wróbel T; Jaźwiec B; Mazur G; Butrym A; Poręba R; Kuliczkowski K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e217-21. PubMed ID: 20491995
[TBL] [Abstract][Full Text] [Related]
9. Micropapillary transitional cell carcinoma of the urinary bladder.
López JI; Elorriaga K; Imaz I; Bilbao FJ
Histopathology; 1999 Jun; 34(6):561-2. PubMed ID: 10383706
[No Abstract] [Full Text] [Related]
10. [Bone morphogenetic protein (BMP) receptors and signal transduction].
Yamashita H; Miyazono K
Nihon Rinsho; 1999 Jan; 57(1):220-6. PubMed ID: 10036966
[TBL] [Abstract][Full Text] [Related]
11. BMPs and BMPRs in chicken ovary and effects of BMP-4 and -7 on granulosa cell proliferation and progesterone production in vitro.
Onagbesan OM; Bruggeman V; Van As P; Tona K; Williams J; Decuypere E
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E973-83. PubMed ID: 12888485
[TBL] [Abstract][Full Text] [Related]
12. The role of bone morphogenetic proteins in ovarian function.
Shimasaki S; Moore RK; Erickson GF; Otsuka F
Reprod Suppl; 2003; 61():323-37. PubMed ID: 14635945
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro.
Suzawa M; Takeuchi Y; Fukumoto S; Kato S; Ueno N; Miyazono K; Matsumoto T; Fujita T
Endocrinology; 1999 May; 140(5):2125-33. PubMed ID: 10218963
[TBL] [Abstract][Full Text] [Related]
14. Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2.
Wen H; Feng CC; Ding GX; Meng DL; Ding Q; Fang ZJ; Xia GW; Xu G; Jiang HW
Ann Diagn Pathol; 2013 Jun; 17(3):259-64. PubMed ID: 23276457
[TBL] [Abstract][Full Text] [Related]
15. [An experimental study of attachment to collagen, utilizing an established cell line of human urinary bladder cancer (T24)].
Hirano K
Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1754-63. PubMed ID: 3444168
[No Abstract] [Full Text] [Related]
16. Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice.
Kyriazis AA; Kyriazis AP; McCombs WB; Peterson WD
Cancer Res; 1984 Sep; 44(9):3997-4005. PubMed ID: 6744315
[TBL] [Abstract][Full Text] [Related]
17. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells.
Kim IY; Lee DH; Lee DK; Ahn HJ; Kim MM; Kim SJ; Morton RA
Oncogene; 2004 Oct; 23(46):7651-9. PubMed ID: 15354178
[TBL] [Abstract][Full Text] [Related]
19. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM
Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein signaling in the developing kidney: present and future.
Cain JE; Hartwig S; Bertram JF; Rosenblum ND
Differentiation; 2008 Oct; 76(8):831-42. PubMed ID: 18331343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
